Explore comprehensive CDMO services offered by HAS Healthcare Advanced Synthesis, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. HAS Healthcare Advanced Synthesis enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Switzerland
Description: HAS Healthcare Advanced Synthesis is a Swiss-based contract development and manufacturing organization (CDMO) that specializes in producing active pharmaceutical ingredients (APIs), cGMP advanced intermediates, high-potency APIs (HPAPIs), and anticancer compounds. Located in Biasca, Switzerland, the company serves third parties exclusively, from clinical phases to commercial supply. Established in 1984, HAS works with clients on tailored solutions, particularly in oncology and rare diseases.
